EMA — authorised 2 September 2011
- Status: approved
EMA authorised Afinitor on 2 September 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 2 September 2011.
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.